menu
    • menu
    [{"orgOrder":0,"company":"Neurotune","sponsor":"Cross Research S.A. | Triclinium clinical trial project managment LTD","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Dimiracetam","moa":"nootropes (piracetam type)","graph1":"Neurology","graph2":"Phase II","graph3":"Neurotune","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Neurotune \/ Cross Research S.A. | Triclinium clinical trial project managment LTD","highestDevelopmentStatusID":"8","companyTruncated":"Neurotune \/ Cross Research S.A. | Triclinium clinical trial project managment LTD"},{"orgOrder":0,"company":"Neurotune","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Dimiracetam","moa":"nootropes (piracetam type)","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Neurotune","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Neurotune \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Neurotune \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals for Dimiracetam

    Menu

    Dimiracetam

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Neurotune

                            Country arrow
                            BOS Manchester
                            Not Confirmed

                            Neurotune

                            Country arrow
                            BOS Manchester
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dimiracetam

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Dimiracetam in Painful Neuropathies Affecting AIDS Patients

                            Details : Dimiracetam is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Acquired Immunodeficiency Syndrome.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            October 03, 2011

                            Lead Product(s) : Dimiracetam

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Neurotune

                            Country arrow
                            BOS Manchester
                            Not Confirmed

                            Neurotune

                            Country arrow
                            BOS Manchester
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dimiracetam

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Cross Research S.A. | Triclinium clinical trial project managment LTD

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful N...

                            Details : Dimiracetam is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Neuropathy.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            June 02, 2010

                            Lead Product(s) : Dimiracetam

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Cross Research S.A. | Triclinium clinical trial project managment LTD

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth